Director Alison Cornell Buys Nearly $100K in Zivo Bioscience Stock
Summary
Zivo Bioscience Director Alison A. Cornell made an open market purchase of company stock totaling approximately $99,995, signaling confidence in the company.
Key Events
-
Director Stock Purchase
Alison A. Cornell, a Director of Zivo Bioscience, acquired 11,709 shares of common stock in an open market transaction on January 26, 2026, for a total value of approximately $99,995.
-
Insider Accumulation Trend
This purchase by a director follows a recent open market buy of similar value by the company's President and CEO, indicating a broader trend of insider accumulation.
Analysis
Director Alison A. Cornell's open market purchase of approximately $99,995 in Zivo Bioscience stock is a notable signal of confidence. This transaction, representing a significant investment for a director, suggests an insider belief in the company's future prospects or that its shares are currently undervalued. This purchase follows a recent similar-sized open market buy by the President and CEO, indicating a pattern of insider accumulation within the company.
At the time of this filing, ZIVO was trading at $9.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $35M. The 52-week trading range was $6.95 to $22.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.